Hanneke Weitering, staff writer at Space.com, discusses Vodafone Germany teaming up with Nokia to bring a 4G network to the moon. The network will allow astronauts to stream HD video back to Earth on an upcoming mission.
Weitering explains there won't be any cellphone towers built on the moon, but the entire network will be in a super portable device no larger than a bag of sugar.
Weitering also discusses the University of Central Florida's decision to take over control of the Arecibo Observatory in Puerto Rico. Many people worried the world's second largest radio telescope would shut down after Hurricane Maria. Weitering says the telescope is an essential piece of tech in the search for extraterrestrial life.
Weitering also tells us that March will be the second month in 2018 to have two full moons in one month. The last time this happened was in 1999 and the next time will be in 2037.
Australia’s Great Barrier Reef is spawning in an explosion of color as the World Heritage-listed natural wonder recovers from life-threatening coral bleaching episodes.
Climate change that may have contributed to a lobster boom in Maine could soon lead to a bust. Chloe Aiello reports.
Good Morning America co-host Michael Strahan will be among the crew on Blue Origin’s next flight to space.
President Joe Biden is ordering a record-setting 50 million barrels of oil released from America's strategic reserve to help bring down energy costs.
All the news you Need2Know for Tuesday, November 23, 2021.
The U.S. is moving to open up COVID-19 booster shots to all adults, letting them choose another dose of either the Pfizer or Moderna vaccine.
U.S. health officials say an estimated 100,000 Americans died of drug overdoses in one year. That's a total the nation has never seen.
Russian officials on Tuesday rejected accusations that they endangered astronauts aboard the International Space Station by conducting a weapons test that created more than 1,500 pieces of space junk.
Austria has taken what its leader called the “dramatic” step of implementing a nationwide lockdown for unvaccinated people who haven’t recently had COVID-19.
Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.
